Background
A founder mutation was recently discovered and described as conferring
favorable lipid profiles and reduced subclinical atherosclerotic disease in a
Pennsylvania Amish population. Preliminary data have suggested that this null mutation
APOC3 R19X (rs76353203) is rare in the general population.
Methods and Results
To better describe the frequency and lipid profile in the general population,
we as part of the Population Architecture using Genomics and Epidemiology (PAGE) I study
and the Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study
genotyped rs76353203 in 1,113 Amish participants from Ohio and Indiana and 19,613
participants from the National Health and Nutrition Examination Surveys (NHANES III,
1999–2002, and 2007–2008). We found no carriers among the Ohio and
Indiana Amish. Out of the 19,613 NHANES participants, we identified 31 participants
carrying the 19X allele, for an overall allele frequency of 0.08%. Among fasting
adults, the 19X allele was associated with lower TG (n=7,603; β=
−71.20; p = 0.007) and higher HDL-C (n=8,891; β
= 15.65; p = 0.0002) and, although not significant, lower LDL-C
(n=6,502; β= −4.85; p = 0.68) after adjustment
for age, sex and race/ethnicity. On average, 19X allele participants had approximately
half the TG levels (geometric means 51.3–69.7 vs. 134.6–141.3 mg/dl),
>20% higher HDL-C levels (geometric means 56.8–74.4 vs.
50.38–53.36 mg/dl), and lower LDL-C levels (geometric means 104.5–128.6
vs. 116.1–125.7 mg/dl) compared with non-carrier participants.
Conclusions
These data demonstrate that APOC3 19X exists in the general US
population in multiple racial/ethnic groups and is associated with cardio-protective
lipid profiles.